Diabetes in Cushing syndrome: basic and clinical aspects

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502 · see citing works

Diagnosis and Classification of Diabetes Mellitus

Basevi, V. (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 21,302 · see citing works

Diagnosis and complications of Cushing’s syndrome: a consensus statement

Arnaldi, G., Angeli, A., Atkinson, A. B., Bertagna, X., Cavagnini, F., Chrousos, G. P., Fava, G. A., Findling, J. W., Gaillard, R. C., Grossman, A. B., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030871 · Cited by 1,362 · see citing works

Growth Hormone, Insulin-Like Growth Factors, and the Skeleton

Giustina, A., Mazziotti, G., & CANALIS, E. M. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0036 · Cited by 910 · see citing works

Treatment of adrenocorticotropin-dependent Cushing’s syndrome: a consensus statement

Biller, B. M. K., Grossman, A. B., Stewart, P. M., Melmed, S., Bertagna, X., Bertherat, J., Buchfelder, M., Colao, A., Hermus, A. R., Hofland, L. J., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2734 · Cited by 853 · see citing works

Guidelines for Acromegaly Management: An Update

Melmed, S. K., Colao, A., Barkan, A. L., Molitch, M. E., Grossman, A. B., Kleinberg, D. L., Clemmons, D. R., Chanson, P., Laws, E. R., Schlechte, J., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2421 · Cited by 762 · see citing works

Rosiglitazone Evaluated for Cardiovascular Outcomes — An Interim Analysis

Home, P. D., Pocock, S. J., Beck-Nielsen, H., Gomis, R., Hanefeld, M., Jones, N. P., Komajda, M., & McMurray, J. J. V. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa073394 · Cited by 761 · see citing works

Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years

Klonoff, D. C., Buse, J. B., Nielsen, L. L., Guan, X., Bowlus, C. L., Holcombe, J. H., Wintle, M. E., & Maggs, D. G. (2008) · Current Medical Research and Opinion · doi:10.1185/030079908x253870 · Cited by 699 · see citing works

Morbidity and mortality in Cushing's disease: an epidemiological approach.

Etxabe, J., & Vazquez, J. A. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02486.x · Cited by 622 · see citing works

Glucocorticoid-induced hyperglycemia

Clore, J. N., & Thurby-Hay, L. (2009) · Endocrine Practice · doi:10.4158/ep08331.rar · Cited by 508 · see citing works

Persistence of Increased Cardiovascular Risk in Patients with Cushing's Disease after Five Years of Successful Cure

Colao, A., Pivonello, R., Spiezia, S., Faggiano, A., Ferone, D., Filippella, M., Marzullo, P., Cerbone, G., Siciliani, M., & Lombardi, G. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.8.5896 · Cited by 448 · see citing works

Novel insights into glucocorticoid‐mediated diabetogenic effects: towards expansion of therapeutic options?

Van Raalte, D. H., Ouwens, D. M., & Diamant, M. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2008.02067.x · Cited by 439 · see citing works

Transsphenoidal Microsurgery for Cushing’s Disease: Initial Outcome and Long-Term Results

Hammer, G. D., Tyrrell, J., Lamborn, K. R., Applebury, C. B., Hannegan, E. T., Bell, S. A., Rahl, R., Lu, A., & Wilson, C. B. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032180 · Cited by 376 · see citing works

Mortality and Morbidity in Cushing's Disease over 50 Years in Stoke-on-Trent, UK: Audit and Meta-Analysis of Literature

Clayton, R. N., Raskauskiene, D., Reulen, R. C., & Jones, P. W. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1942 · Cited by 373 · see citing works

Glucocorticoid-induced osteoporosis: an update

Mazziotti, G., Angeli, A., Bilezikian, J. P., Canalis, E., & Giustina, A. (2006) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2006.03.009 · Cited by 362 · see citing works

American Association of clinical endocrinologists and American association of endocrine surgeons medical guidelines for the management of adrenal incidentalomas: executive summary of recommendations

Zeiger, M. A., Thompson, G. B., Duh, Q.-Y., Hamrahian, A. H., Angelos, P., Elaraj, D., Fishman, E., Kharlip, J., Hamrahian, A. H., Garber, J. R., et al. (2009) · Endocrine Practice · doi:10.4158/ep.15.5.450 · Cited by 333 · see citing works

The Medical Treatment of Cushing’s Disease: Effectiveness of Chronic Treatment with the Dopamine Agonist Cabergoline in Patients Unsuccessfully Treated by Surgery

Pivonello, R., Martino, M. C. D., Cappabianca, P., Leo, M. D., Faggiano, A., Lombardi, G., Hofland, L. J., Lamberts, S. W. J., & Colao, A. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1533 · Cited by 328 · see citing works

The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients

Filipsson, H., Monson, J. P., Koltowska-Häggström, M., Mattsson, A., & Johannsson, G. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0524 · Cited by 321 · see citing works

Glucocorticoids and the risk for initiation of hypoglycemic therapy

Gurwitz, J. H. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420010131015 · Cited by 314 · see citing works

Apelin, diabetes, and obesity

Castan‐Laurell, I., Dray, C., Attané, C., Duparc, T., Knauf, C., & Valet, P. (2011) · Endocrine · doi:10.1007/s12020-011-9507-9 · Cited by 297 · see citing works

Subclinical Cushing’s syndrome

Reincke, M. (2000) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70115-8 · Cited by 285 · see citing works

Diagnosis and Treatment of Subclinical Hypercortisolism

Chiodini, I. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2722 · Cited by 279 · see citing works

High cardiovascular risk in patients with Cushing’s syndrome according to 1999 WHO/ISH guidelines

Mancini, T., Kola, B., Mantero, F., Boscaro, M., & Arnaldi, G. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02168.x · Cited by 278 · see citing works

Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial.

Boscaro, M., Ludlam, W., Atkinson, B., Glusman, J., Petersenn, S., Reincke, M., Snyder, P. J., Tabarin, A., Biller, B., Findling, J., et al. (2009) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jc.2008-1008 · Cited by 276 · see citing works

Gender-Related Differences in the Presentation and Course of Cushing’s Disease

Giraldi, F. P., Moro, M., & Cavagnini, F. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021518 · Cited by 260 · see citing works

Drug-induced Osteoporosis: Mechanisms and Clinical Implications

Mazziotti, G., CANALIS, E. M., & Giustina, A. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2010.02.028 · Cited by 259 · see citing works

Pasireotide alone or with cabergoline and ketoconazole in Cushing's disease.

Feelders, R., de Bruin, C., Pereira, A., Romijn, J., Netea-Maier, R., Hermus, A., Zelissen, P., van Heerebeek, R. E. A., de Jong, F. D., van der Lely, A. J., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmc1000094 · Cited by 251 · see citing works

Prevalence and predictors of corticosteroid-related hyperglycemia in hospitalized patients

Donihi, A. C., Raval, D., Saul, M., Korytkowski, M. T., & DeVita, M. A. (2006) · Endocrine Practice · doi:10.4158/ep.12.4.358 · Cited by 246 · see citing works

Adipocyte-Derived Hormones, Cytokines, and Mediators

Rondinone, C. M. (2006) · Endocrine · doi:10.1385/endo:29:1:81 · Cited by 246 · see citing works

Bromocriptine: a novel approach to the treatment of type 2 diabetes.

Pijl, H., Ohashi, S., Matsuda, M., Miyazaki, Y., Mahankali, A., Kumar, V., Pipek, R., Iozzo, P., Lancaster, J. L., Cincotta, A. H., et al. (2000) · Diabetes Care · doi:10.2337/diacare.23.8.1154 · Cited by 238 · see citing works

Effects of Somatostatin Analogs on Glucose Homeostasis: A Metaanalysis of Acromegaly Studies

Mazziotti, G., Floriani, I., Bonadonna, S., Torri, V., Chanson, P., & Giustina, A. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2332 · Cited by 225 · see citing works

Mortality in Patients Treated for Cushing’s Disease Is Increased, Compared with Patients Treated for Nonfunctioning Pituitary Macroadenoma

Dekkers, O. M., Biermasz, N. R., Pereira, A. M., Roelfsema, F., van Aken, M. O., Voormolen, J. H. C., & Romijn, J. A. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2112 · Cited by 222 · see citing works

Continuous monitoring of circadian glycemic patterns in patients receiving prednisolone for COPD

Burt, M. G., Roberts, G. W., Aguilar-Loza, N. R., Frith, P., & Stranks, S. N. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2729 · Cited by 203 · see citing works

Pathophysiology of Diabetes Mellitus in Cushing’s Syndrome

Pivonello, R., De Leo, M., Vitale, P., Cozzolino, A., Simeoli, C., De Martino, M. C., Lombardi, G., & Colao, A. (2010) · Neuroendocrinology · doi:10.1159/000314319 · Cited by 190 · see citing works

Glucagon-Like Peptide-1 Receptor Agonist Treatment Prevents Glucocorticoid-Induced Glucose Intolerance and Islet-Cell Dysfunction in Humans

van Raalte, D. H., van Genugten, R. E., Linssen, M. M. L., Ouwens, D. M., & Diamant, M. (2011) · Diabetes Care · doi:10.2337/dc10-1677 · Cited by 148 · see citing works

Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities

Resmini, E., Minuto, F., Colao, A., & Ferone, D. (2009) · Acta Diabetologica · doi:10.1007/s00592-009-0112-9 · Cited by 147 · see citing works

Carbohydrate and lipid metabolism in endogenous hypercortisolism: shared features with metabolic syndrome X and NIDDM

FRIEDMAN, T. C., MASTORAKOS, G., NEWMAN, T. D., MULLEN, N. M., HORTON, E. G., COSTELLO, R., PAPADOPOULOS, N. M., & CHROUSOS, G. P. (1996) · Endocrine Journal · doi:10.1507/endocrj.43.645 · Cited by 145 · see citing works

Effects of chronic administration of PPAR-gamma ligand rosiglitazone in Cushing's disease

Ambrosi, B., Dall’Asta, C., Cannavò, S., Libé, R., Vigo, T., Epaminonda, P., Chiodini, I., Ferrero, S., Trimarchi, F., Arosio, M., et al. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1510173 · Cited by 144 · see citing works

Growth Hormone and Cardiovascular Risk Factors

Gola, M., Bonadonna, S., Doga, M., & Giustina, A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0545 · Cited by 135 · see citing works

Implications of Using Hemoglobin A1C for Diagnosing Diabetes Mellitus

Malkani, S., & Mordes, J. P. (2011) · The American Journal of Medicine · doi:10.1016/j.amjmed.2010.11.025 · Cited by 125 · see citing works

LXRβ is required for glucocorticoid-induced hyperglycemia and hepatosteatosis in mice

Patel, R., Patel, M., Tsai, R., Lin, V. Y., Bookout, A. L., Zhang, Y., Magomedova, L., Li, T., Chan, J. F., Budd, C., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41681 · Cited by 119 · see citing works

Risk and mechanism of dexamethasone-induced deterioration of glucose tolerance in non-diabetic first-degree relatives of NIDDM patients

Alford, F., Beck-Nielsen, H., Ward, G. M., & Henriksen, J. E. (1997) · Diabetologia · doi:10.1007/s001250050847 · Cited by 115 · see citing works

Diabetes-Haufigkeit bei Akromegalie und Cushing-Syndrom

Biering, H., Knappe, G., Gerl, H., & Lochs, H. (2000) · Acta Medica Austriaca · doi:10.1046/j.1563-2571.2000.00106.x · Cited by 113 · see citing works

Reduced Glucose Tolerance and Insulin Resistance Induced by Steroid Treatment, Relative Physical Inactivity, and High-Calorie Diet Impairs the Incretin Effect in Healthy Subjects

Hansen, K. B., Vilsbøll, T., Bagger, J. I., Holst, J. J., & Knop, F. K. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0119 · Cited by 110 · see citing works

Low-dose glucocorticoid treatment affects multiple aspects of intermediary metabolism in healthy humans: a randomised controlled trial

van Raalte, D. H., Brands, M., van der Zijl, N. J., Muskiet, M. H., Pouwels, P. J. W., Ackermans, M. T., Sauerwein, H. P., Serlie, M. J., & Diamant, M. (2011) · Diabetologia · doi:10.1007/s00125-011-2174-9 · Cited by 109 · see citing works

Glucocorticoids Down-Regulate Somatostatin Receptors on Pituitary Cells in Culture*

Schönbrunn, A. (1982) · Endocrinology · doi:10.1210/endo-110-4-1147 · Cited by 109 · see citing works

Glucocorticoids Regulate Transcription of the Gene for Phosphoenolpyruvate Carboxykinase in the Liver via an Extended Glucocorticoid Regulatory Unit

Cassuto, H., Kochan, K., Chakravarty, K., Cohen, H., Blum, B., Olswang, Y., Hakimi, P., Xu, C., Massillon, D., Hanson, R. W., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504119200 · Cited by 108 · see citing works

Subclinical hypercortisolism: correlation between biochemical diagnostic criteria and clinical aspects

Morelli, V., Masserini, B., Salcuni, A. S., Eller‐Vainicher, C., Savoca, C., Viti, R., Coletti, F., Guglielmi, G., Battista, C., Iorio, L., et al. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03794.x · Cited by 107 · see citing works

Adrenal incidentaloma, clinical, metabolic, follow-up aspects: single centre experience

Comlekci, A., Yener, S., Ertilav, S., Secil, M., Akinci, B., Demir, T., Kebapcilar, L., Bayraktar, F., Yesil, S., & Eraslan, S. (2010) · Endocrine · doi:10.1007/s12020-009-9260-5 · Cited by 96 · see citing works

Midnight serum cortisol as a marker of increased cardiovascular risk in patients with a clinically inapparent adrenal adenoma

Terzolo, M., Bovio, S., Pia, A., Conton, P. A., Reimondo, G., Dall’Asta, C., Bemporad, D., Angeli, A., Opocher, G., Mannelli, M., et al. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01959 · Cited by 89 · see citing works

Colocalization of Somatostatin Receptor sst5 and Insulin in Rat Pancreatic β-Cells*

Warrier, S. R., Mezey, É., Hunyady, B., Chamberlain, L., Hayes, E. C., Foor, F., Wang, Y., Schönbrunn, A., & Schaeffer, J. M. (1999) · Endocrinology · doi:10.1210/endo.140.8.6937 · Cited by 88 · see citing works

Repaglinide versus glibenclamide treatment of Type 2 diabetes during Ramadan fasting

Mafauzy, M. (2002) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(02)00104-3 · Cited by 87 · see citing works

Effect of Pioglitazone on Adrenocorticotropic Hormone and Cortisol Secretion in Cushing’s Disease

Suri, D., & Weiss, R. E. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1746 · Cited by 84 · see citing works

Vertebral fractures in males with type 2 diabetes treated with rosiglitazone

Mancini, T., Mazziotti, G., Doga, M., Carpinteri, R., Simetovic, N., Vescovi, P. P., & Giustina, A. (2009) · Bone · doi:10.1016/j.bone.2009.06.006 · Cited by 84 · see citing works

Effect of protracted treatment with rosiglitazone, a PPARγ agonist, in patients with Cushing's disease

Giraldi, F. P., Scaroni, C. M., Arvat, E., Martin, M. D., Giordano, R., Albiger, N. M. E., Leão, A. A. S., Picu, A., Mantero, F., & Cavagnini, F. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02452.x · Cited by 82 · see citing works

Cell Specific Expression of the SST2A and SST5 Somatostatin Receptors in the Rat Anterior Pituitary

Mezey, É., Hunyady, B., Mitra, S. W., Hayes, E., Liu, Q., Schaeffer, J. M., & Schönbrunn, A. (1998) · Endocrinology · doi:10.1210/endo.139.1.5807 · Cited by 80 · see citing works

Differential Ligand-Mediated Pituitary Somatostatin Receptor Subtype Signaling: Implications for Corticotroph Tumor Therapy

Ben-Shlomo, A., SCHMID, H. A., Wawrowsky, K., Pichurin, O., Hubina, E., Chesnokova, V., Liu, N., Culler, M. D., & Melmed, S. K. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1311 · Cited by 72 · see citing works

Glucocorticoid replacement therapy and vertebral fractures in hypopituitary adult males with GH deficiency

Mazziotti, G., Porcelli, T., Bianchi, A., Cimino, V, Patelli, I., Mejia, C., Fusco, A., Giampietro, A., De Marinis, L., & Giustina, A. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0125 · Cited by 68 · see citing works

Subclinical Cushing's syndrome

Terzolo, M., Bovio, S., Pia, A. R., Osella, G., Borretta, G., Angeli, A., & Reimondo, G. (2007) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302007000800013 · Cited by 67 · see citing works

Treatment of Cushing disease: overview and recent findings

Giustina, A. (2010) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s12952 · Cited by 66 · see citing works

Growth hormone deficiency in the adult

Doga, M., Bonadonna, S., Gola, M., Mazziotti, G., & Giustina, A. (2006) · Pituitary · doi:10.1007/s11102-006-0410-y · Cited by 66 · see citing works

Is there value in routine screening for Cushing’s syndrome in patients with diabetes?

Mullan, K., Black, N., Thiraviaraj, A., Bell, P. M., Burgess, C., Hunter, S. J., McCance, D. R., Leslie, H., Sheridan, B., & Atkinson, A. B. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2453 · Cited by 65 · see citing works

Metabolic, Cardiovascular, and Cerebrovascular Outcomes in Growth Hormone-Deficient Subjects with Previous Cushing’s Disease or Non-Functioning Pituitary Adenoma

Webb, S. M., Mo, D., Lamberts, S. W. J., Melmed, S. K., Cavagnini, F., Giraldi, F. P., Strasburger, C. J., Zimmermann, A. G., Woodmansee, W. W., & on behalf of the International HypoCCS Advisory Board (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0806 · Cited by 63 · see citing works

Insulin resistance induced by hydrocortisone is increased in patients with abdominal obesity

Darmon, P., Dadoun, F., Boullu-Ciocca, S., Grino, M., Alessi, M.-C., & Dutour, A. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00654.2005 · Cited by 59 · see citing works

New-onset diabetes after transplantation--should it be a factor in choosing an immunosuppressant regimen for kidney transplant recipients

Chadban, S. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn052 · Cited by 52 · see citing works

The size of adrenal incidentalomas correlates with insulin resistance. Is there a cause-effect relationship?: The size of AI correlates with insulin resistance

Muscogiuri, G., Sorice, G. P., Prioletta, A., Mezza, T., Cipolla, C., Salomone, E., Giaccari, A., Pontecorvi, A., & Della Casa, S. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03928.x · Cited by 52 · see citing works

Transient Efficacy of Octreotide and Pasireotide (SOM230) Treatment in GIP-dependent Cushing's Syndrome

Preumont, V., Mermejo, L. M., Damoiseaux, P., Lacroix, A., & Maiter, D. M. (2011) · Hormone and Metabolic Research · doi:10.1055/s-0030-1270523 · Cited by 51 · see citing works

Effects of high-dose octreotide LAR on glucose metabolism in patients with acromegaly inadequately controlled by conventional somatostatin analog therapy

Mazziotti, G., Porcelli, T., Bogazzi, F., Bugari, G., Cannavò, S., Colao, A. A. L., Cozzi, R. C., Marinis, L. D., Uberti, E. C. D., Grottoli, S., et al. (2011) · European Journal of Endocrinology · doi:10.1530/eje-10-0811 · Cited by 49 · see citing works

Medical Treatment of Cushing’s Disease: Somatostatin Analogues and Pasireotide

Pedroncelli, A. M. (2010) · Neuroendocrinology · doi:10.1159/000314352 · Cited by 39 · see citing works

Pasireotide (SOM230), a Novel Multireceptor‐Targeted Somatostatin Analogue, Is Well Tolerated When Administered as a Continuous 7‐Day Subcutaneous Infusion in Healthy Male Volunteers

Petersenn, S., Unger, N., Hu, K., Weisshaar, B., Zhang, Y., Bouillaud, E., Reséndiz, K. H., Wang, Y.-F., & Mann, K. (2012) · Journal of clinical pharmacology · doi:10.1177/0091270011408727 · Cited by 36 · see citing works

Colocalization of Somatostatin Receptor sst5 and Insulin in Rat Pancreatic -Cells

Mitra, S. W. (1999) · Endocrinology · doi:10.1210/en.140.8.3790 · Cited by 33 · see citing works

Safety profile and metabolic effects of 14 days of treatment with DIO-902: results of a phase IIa multicenter, randomized, double-blind, placebo-controlled, parallel-group trial in patients with type 2 diabetes mellitus

SCHWARTZ, S., RENDELL, M., AHMANN, A., THOMAS, A., ARAUZPACHECO, C., & WELLES, B. (2008) · Clinical Therapeutics · doi:10.1016/j.clinthera.2008.05.021 · Cited by 29 · see citing works

Pancreatic β-cell signaling: toward better understanding of diabetes and its treatment

Seino, S., Shibasaki, T., & Minami, K. (2010) · Proceedings of the Japan Academy. Series B, Physical and biological sciences · doi:10.2183/pjab.86.563 · Cited by 28 · see citing works

Low-dose octreotide is able to cause a maximal inhibition of the glycemic responses to a mixed meal in obese type 2 diabetic patients treated with insulin

GIUSTINA, A., Girelli, A., Buffoli, M. G., Cimino, A., Legati, F., Valentini, U., & Giustina, G. (1991) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(91)90052-f · Cited by 19 · see citing works

U.S. FDA Approved Drugs from 2015–June 2020: A Perspective

Bhutani, P., Joshi, G., Raja, N., Bachhav, N., Rajanna, P. K., Bhutani, H., Paul, A. T., & Kumar, R. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01786 · Cited by 815 · see citing works

Steroid‐induced diabetes: a clinical and molecular approach to understanding and treatment

Hwang, J. L., & Weiss, R. E. (2013) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2486 · Cited by 385 · see citing works

Long-Term Exposure to Road Traffic Noise and Incident Diabetes: A Cohort Study

Sørensen, M., Andersen, Z. J., Nordsborg, R. B., Becker, T., Tjønneland, A. M., Overvad, K., & Raaschou‐Nielsen, O. (2012) · Environmental Health Perspectives · doi:10.1289/ehp.1205503 · Cited by 345 · see citing works

Growth Hormone, Insulin-Like Growth Factor-1, and the Kidney: Pathophysiological and Clinical Implications

Kamenický, P., Mazziotti, G., Lombès, M., Giustina, A., & Chanson, P. (2013) · Endocrine Reviews · doi:10.1210/er.2013-1071 · Cited by 243 · see citing works

Systemic Glucocorticoid Therapy: a Review of its Metabolic and Cardiovascular Adverse Events

Fardet, L., & Fève, B. (2014) · Drugs · doi:10.1007/s40265-014-0282-9 · Cited by 239 · see citing works

Treating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good From the Bad ?

Pofi, R., Caratti, G., Ray, D. W., & Tomlinson, J. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad016 · Cited by 225 · see citing works

Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?

Klil-Drori, A. J., Azoulay, L., & Pollak, M. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.120 · Cited by 207 · see citing works

Glucocorticoids and the regulation of growth hormone secretion

Mazziotti, G., & Giustina, A. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.5 · Cited by 206 · see citing works

The Pathophysiology of Hyperglycemia in Older Adults: Clinical Considerations

Lee, P., & Halter, J. B. (2017) · Diabetes Care · doi:10.2337/dc16-1732 · Cited by 211 · see citing works

Metabolic comorbidities in Cushing's syndrome

Ferraù, F., & Korbonits, M. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0354 · Cited by 223 · see citing works

Pathobiological mechanisms underlying metabolic syndrome (MetS) in chronic obstructive pulmonary disease (COPD): clinical significance and therapeutic strategies

Chan, S. M. H., Selemidis, S., Bozinovski, S., & Vlahos, R. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.02.013 · Cited by 180 · see citing works

Glucocorticoids and bone: Local effects and systemic implications

Henneicke, H., Gasparini, S. J., Brennan-Speranza, T. C., Zhou, H., & Seibel, M. J. (2014) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2013.12.006 · Cited by 168 · see citing works

Managing hyperglycemia in patients with Cushing’s disease treated with pasireotide: medical expert recommendations

Colao, A., Block, C. E. M. D., Gaztambide, M. S., Kumar, S., Seufert, J., & Casanueva, F. F. (2013) · Pituitary · doi:10.1007/s11102-013-0483-3 · Cited by 150 · see citing works

Glucocorticoid-Induced Fatty Liver Disease

Rahimi, L., Rajpal, A., & Ismail-Beigi, F. (2020) · Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy · doi:10.2147/dmso.s247379 · Cited by 120 · see citing works

Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management

Scaroni, C., Zilio, M., Foti, M., & Boscaro, M. (2017) · Endocrine Reviews · doi:10.1210/er.2016-1105 · Cited by 140 · see citing works

Selective Progesterone Receptor Modulators—Mechanisms and Therapeutic Utility

Islam, M. S., Afrin, S., Jones, S. I., & Segars, J. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa012 · Cited by 143 · see citing works

Current and Emerging Aspects of Diabetes Mellitus in Acromegaly

Frara, S., Maffezzoni, F., Mazziotti, G., & Giustina, A. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.04.014 · Cited by 138 · see citing works

New Insights into the Role of Insulin and Hypothalamic-Pituitary-Adrenal (HPA) Axis in the Metabolic Syndrome

Janssen, J. A. M. J. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158178 · Cited by 134 · see citing works

New mechanisms of glucocorticoid-induced insulin resistance: make no bones about it

Ferris, H. A., & Kahn, C. R. (2012) · Journal of Clinical Investigation · doi:10.1172/jci66180 · Cited by 131 · see citing works

Chronic Stress and Diabetes Mellitus: Interwoven Pathologies

Sharma, V. K., & Singh, T. G. (2020) · Current Diabetes Reviews · doi:10.2174/1573399815666191111152248 · Cited by 116 · see citing works

Steroid-induced hyperglycemia: An underdiagnosed problem or clinical inertia? A narrative review

Bonaventura, A., & Montecucco, F. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.03.006 · Cited by 108 · see citing works

Association between Higher Serum Cortisol Levels and Decreased Insulin Secretion in a General Population

KAMBA, A., Daimon, M., Murakami, H., Otaka, H., Matsuki, K., Sato, E., Tanabe, J., Takayasu, S., Matsuhashi, Y., Yanagimachi, M., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166077 · Cited by 100 · see citing works

COVID-19 and the pituitary

Frara, S., Allora, A., Castellino, L., di Filippo, L., Loli, P., & Giustina, A. (2021) · Pituitary · doi:10.1007/s11102-021-01148-1 · Cited by 97 · see citing works

Management of endocrine disease: risk of overtreatment in patients with adrenal insufficiency: current and emerging aspects

Mazziotti, G., Formenti, A. M., Frara, S., Roca, E., Mortini, P., Berruti, A., & Giustina, A. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0154 · Cited by 96 · see citing works

Effects of chronic noise on glucose metabolism and gut microbiota–host inflammatory homeostasis in rats

Cui, B., Gai, Z., She, X., Wang, R., & Xi, Z. (2016) · Scientific Reports · doi:10.1038/srep36693 · Cited by 93 · see citing works

Metabolomics Based Profiling of Dexamethasone Side Effects in Rats

Malkawi, A. K., Alzoubi, K. H., Jacob, M., Matic, G., Ali, A., Faraj, A. A., Al-Mohanna, F., Dasouki, M., & Rahman, A. M. A. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00046 · Cited by 95 · see citing works

Screening for potential novel probiotic Lactobacillus strains based on high dipeptidyl peptidase IV and α-glucosidase inhibitory activity

Zeng, Z., Luo, J., Zuo, F., Zhang, Y., Ma, H., & Chen, S. (2015) · Journal of Functional Foods · doi:10.1016/j.jff.2015.11.030 · Cited by 94 · see citing works

Postoperative diabetes insipidus: how to define and grade this complication?

de Vries, F., Lobatto, D. J., Verstegen, M. J. T., van Furth, W. R., Pereira, A. M., & Biermasz, N. R. (2020) · Pituitary · doi:10.1007/s11102-020-01083-7 · Cited by 93 · see citing works

Advances in the epidemiology, pathogenesis, and management of Cushing’s syndrome complications

Arnaldi, G., Mancini, T., Tirabassi, G., Trementino, L., & Boscaro, M. (2012) · Journal of Endocrinological Investigation · doi:10.1007/bf03345431 · Cited by 85 · see citing works

Is diabetes in Cushing’s syndrome only a consequence of hypercortisolism?

Giordano, C., Guarnotta, V., Pivonello, R., Amato, M. C., Simeoli, C., Ciresi, A., Cozzolino, A., & Colao, A. (2014) · European Journal of Endocrinology · doi:10.1530/eje-13-0754 · Cited by 79 · see citing works

The Effects of Acute and Chronic Stress on Diabetes ControlA Presentation from the European Society for Paediatric Endocrinology (ESPE) New Inroads to Child Health (NICHe) Conference on Stress Response and Child Health in Heraklion, Crete, Greece, 18 to 20 May 2012.

Marcovecchio, M. L., & Chiarelli, F. (2012) · Science Signaling · doi:10.1126/scisignal.2003508 · Cited by 79 · see citing works

Diabetes Mellitus Secondary to Cushing’s Disease

Barbot, M., Ceccato, F., & Scaroni, C. M. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00284 · Cited by 78 · see citing works

Screening for Potential Novel Probiotics With Dipeptidyl Peptidase IV-Inhibiting Activity for Type 2 Diabetes Attenuation in vitro and in vivo

Yan, F., Li, N., Yue, Y., Wang, C., Zhao, L., Evivie, S. E., Li, B., & Huo, G. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02855 · Cited by 76 · see citing works

Mechanisms in endocrinology: endogenous subclinical hypercortisolism and bone: a clinical review

Chiodini, I., Vainicher, C. E., Morelli, V, Palmieri, S., Cairoli, E., Salcuni, A. S., Copetti, M., & Scillitani, A. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0289 · Cited by 73 · see citing works

Influence of glucocorticoids and growth hormone on insulin sensitivity in humans

Yuen, K. C. J., Chong, L. E., & Riddle, M. (2013) · Diabetic Medicine · doi:10.1111/dme.12184 · Cited by 69 · see citing works

Neurobiological Implications of Chronic Stress and Metabolic Dysregulation in Inflammatory Bowel Diseases

Sic, A., Cvetkovic, K., Manchanda, E., & Knezevic, N. N. (2024) · Diseases · doi:10.3390/diseases12090220 · Cited by 65 · see citing works

Human adipose dynamics and metabolic health

Feng, B., Zhang, T., & Xu, H. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12009 · Cited by 65 · see citing works

Glucose metabolism in patients with subclinical Cushing’s syndrome

Giordano, R., Guaraldi, F., Berardelli, R., Karamouzis, I., D’Angelo, V., Marinazzo, E., Picu, A., Ghigo, E., & Arvat, E. (2012) · Endocrine · doi:10.1007/s12020-012-9628-9 · Cited by 63 · see citing works

The Prediction and Monitoring of Toxicity Associated with Long-Term Systemic Glucocorticoid Therapy

Harris, E., Tiganescu, A., Tubeuf, S., & Mackie, S. L. (2015) · Current Rheumatology Reports · doi:10.1007/s11926-015-0513-4 · Cited by 63 · see citing works

Screening for lactic acid bacteria based on antihyperglycaemic and probiotic potential and application in synbiotic set yoghurt

Muganga, L., Liu, X., Tian, F., Zhao, J., Zhang, H., & Chen, W. (2015) · Journal of Functional Foods · doi:10.1016/j.jff.2015.04.030 · Cited by 62 · see citing works

Treatment of skeletal impairment in patients with endogenous hypercortisolism: when and how?

On behalf of ABC Group, Scillitani, A., Mazziotti, G., Di Somma, C., Moretti, S., Stigliano, A., Pivonello, R., Giustina, A., & Colao, A. (2014) · Osteoporosis International · doi:10.1007/s00198-013-2588-y · Cited by 62 · see citing works

Role of vitamin D in diabetic retinopathy: Pathophysiological and clinical aspects

Tecilazich, F., Formenti, A. M., & Giustina, A. (2020) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09575-4 · Cited by 58 · see citing works

Management of hyperglycaemia in Cushing's disease: Experts’ proposals on the use of pasireotide

Reznik, Y., Bertherat, J. Y., Borson‐Chazot, F., Brue, T. C., Chanson, P., Cortet‐Rudelli, C., Delemer, B., Tabarin, A., Bisot-Locard, S., & Vergès, B. L. (2012) · Diabetes & Metabolism · doi:10.1016/j.diabet.2012.10.005 · Cited by 57 · see citing works

Mifepristone for Management of C ushing's Syndrome

Morgan, F. H., & Laufgraben, M. J. (2013) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1202 · Cited by 56 · see citing works

Mini-review: pheochromocytomas causing the ectopic ACTH syndrome

Ballav, C., Naziat, A., Mihai, R., Karavitaki, N., Ansorge, O., & Grossman, A. B. (2012) · Endocrine · doi:10.1007/s12020-012-9646-7 · Cited by 53 · see citing works

Continuous corticosterone delivery via the drinking water or pellet implantation: A comparative study in mice

Gasparini, S. J., Weber, M.-C., Henneicke, H., Kim, S., Zhou, H., & Seibel, M. J. (2016) · Steroids · doi:10.1016/j.steroids.2016.10.008 · Cited by 52 · see citing works

Salivary Electrochemical Cortisol Biosensor Based on Tin Disulfide Nanoflakes

Liu, X., Hsu, S. P. C., Liu, W., Wang, Y.-M., Liu, X., Lo, C.-S., Lin, Y.-C., Nabilla, S. C., Li, Z., Hong, Y., et al. (2019) · Nanoscale Research Letters · doi:10.1186/s11671-019-3012-0 · Cited by 52 · see citing works

The treatment with pasireotide in Cushing’s disease: effects of long-term treatment on tumor mass in the experience of a single center

Simeoli, C., Auriemma, R. S., Tortora, F., Leo, M. D., Iacuaniello, D., Cozzolino, A., Martino, M. C. D., Pivonello, C., Mainolfi, C. G., Rossi, R., et al. (2015) · Endocrine · doi:10.1007/s12020-015-0557-2 · Cited by 50 · see citing works

Diabetes in Cushing Disease

Mazziotti, G., Formenti, A., Frara, S., Maffezzoni, F., Doga, M., & Giustina, A. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0860-9 · Cited by 45 · see citing works

Cardiometabolic profile of non-functioning and autonomous cortisol-secreting adrenal incidentalomas. Is the cardiometabolic risk similar or are there differences?

Castro, M. A., Lázaro, C. R., Ramírez, P. A. P., Hernández, M. C., Núñez, M. A. S., & Marazuela, M. (2019) · Endocrine · doi:10.1007/s12020-019-02066-w · Cited by 44 · see citing works

Effects of Medical Treatment of Prostate Cancer on Bone Health

Formenti, A. M., Volta, A. D., di Filippo, L., Berruti, A., & Giustina, A. (2021) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2020.12.004 · Cited by 45 · see citing works

Adverse impact of nocturnal transportation noise on glucose regulation in healthy young adults: Effect of different noise scenarios

Thiesse, L., Rudzik, F., Spiegel, K., Leproult, R., Pieren, R., Wunderli, J. M., Foraster, M., Héritier, H., Eze, I. C., Meyer, M., et al. (2018) · Environment International · doi:10.1016/j.envint.2018.05.036 · Cited by 43 · see citing works

Osteopathy in mild adrenal Cushing’s syndrome and Cushing disease

Frara, S., Allora, A., di Filippo, L., Formenti, A. M., Loli, P., Polizzi, E., Tradati, D., Ulivieri, F. M., & Giustina, A. (2021) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2021.101515 · Cited by 43 · see citing works

Glucocorticoid-induced diabetes mellitus in patients with lymphoma treated with CHOP chemotherapy

Lee, S., Kurita, N., Yokoyama, Y., Seki, M., Hasegawa, Y., Okoshi, Y., & Chiba, S. (2013) · Supportive Care in Cancer · doi:10.1007/s00520-013-2097-8 · Cited by 43 · see citing works

Italian Society for the Study of Diabetes (SID)/Italian Endocrinological Society (SIE) guidelines on the treatment of hyperglycemia in Cushing’s syndrome and acromegaly

Baroni, M. G., Giorgino, F., Pezzino, V., Scaroni, C., & Avogaro, A. (2016) · Journal of Endocrinological Investigation · doi:10.1007/s40618-015-0404-6 · Cited by 41 · see citing works

Cardiovascular Manifestations in Rheumatoid Arthritis

Sanghavi, N., Ingrassia, J. P., Korem, S., Ash, J. Y., Pan, S., & Wasserman, A. M. (2022) · Cardiology in Review · doi:10.1097/crd.0000000000000486 · Cited by 40 · see citing works

Octreotide for acromegaly treatment: a reappraisal

Giustina, A., Karamouzis, I., Patelli, I., & Mazziotti, G. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.847090 · Cited by 40 · see citing works

The Modern Criteria for Medical Management of Acromegaly

Frara, S., Maffezzoni, F., Mazziotti, G., & Giustina, A. (2016) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2015.10.015 · Cited by 40 · see citing works

FOXO1-dependent up-regulation of MAP kinase phosphatase 3 (MKP-3) mediates glucocorticoid-induced hepatic lipid accumulation in mice

Feng, B., He, Q., & Xu, H. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.06.001 · Cited by 37 · see citing works

Screening of probiotics with efficient α-glucosidase inhibitory ability and study on the structure and function of its extracellular polysaccharide

Wang, J., Yu, L.-Y., Zeng, X., Zheng, J., Wang, B., & Pan, L. (2021) · Food Bioscience · doi:10.1016/j.fbio.2021.101452 · Cited by 37 · see citing works

Subclinical hypercortisolism in adrenal incidentaloma

Debono, M., & Newell-Price, J. D. C. (2015) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000151 · Cited by 37 · see citing works

Individual-specific functional epigenomics reveals genetic determinants of adverse metabolic effects of glucocorticoids

Hu, W., Jiang, C., Kim, M., Yang, W., Zhu, K., Guan, D., Lv, W., Xiao, Y., Wilson, J. R., Rader, D. J., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.06.004 · Cited by 36 · see citing works

Investigational drugs targeting somatostatin receptors for treatment of acromegaly and neuroendocrine tumors

Giustina, A., Mazziotti, G., Maffezzoni, F., Amoroso, V., & Berruti, A. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.942728 · Cited by 34 · see citing works

Current and future medical treatments for patients with acromegaly

Maffezzoni, F., Formenti, A. M., Mazziotti, G., Frara, S., & Giustina, A. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2016.1199687 · Cited by 34 · see citing works

Investigational anti-hyperglycemic agents: the future of type 2 diabetes therapy?

Majumdar, S. K., & Inzucchi, S. E. (2013) · Endocrine · doi:10.1007/s12020-013-9884-3 · Cited by 32 · see citing works

Mifepristone: is there a place in the treatment of Cushing’s disease?

Carmichael, J., & Fleseriu, M. (2013) · Endocrine · doi:10.1007/s12020-012-9846-1 · Cited by 27 · see citing works

An N-Ethyl-N-Nitrosourea Induced Corticotropin-Releasing Hormone Promoter Mutation Provides a Mouse Model for Endogenous Glucocorticoid Excess

Bentley, L., Esapa, C. T., Nesbit, M. A., Head, R. A., Evans, H., Lath, D., Scudamore, C. L., Hough, T., Podrini, C., Hannan, F. M., et al. (2013) · Endocrinology · doi:10.1210/en.2013-1247 · Cited by 31 · see citing works

Up-to 5-year efficacy of pasireotide in a patient with Cushing’s disease and pre-existing diabetes: literature review and clinical practice considerations

Trementino, L., Cardinaletti, M., Concettoni, C., Marcelli, G., Boscaro, M., & Arnaldi, G. (2014) · Pituitary · doi:10.1007/s11102-014-0582-9 · Cited by 30 · see citing works

Glucose Metabolism in Primary Aldosteronism

Remde, H., Hanslik, G., Rayes, N., & Quinkler, M. O. (2015) · Hormone and Metabolic Research · doi:10.1055/s-0035-1565208 · Cited by 30 · see citing works

An ultrasensitive electrochemical immunosensor based on in-situ growth of CuWO4 nanoparticles on MoS2 and chitosan-gold nanoparticles for cortisol detection

Nong, C., Yang, B., Li, X., Feng, S., & Cui, H. (2022) · Microchemical Journal · doi:10.1016/j.microc.2022.107434 · Cited by 29 · see citing works

Adrenalectomy improves blood pressure control in nonfunctioning adrenal incidentalomas and glycemic and lipid control in patients with autonomous cortisol secretion

Castro, M. A., Ojeda, C. M., Ramírez, M. N. S., Santos, V. G. D., Corrales, E. P., & Fernández-Argüeso, M. (2022) · Endocrine · doi:10.1007/s12020-022-03120-w · Cited by 30 · see citing works

A Novel Antidiabetic Food Produced via Solid-State Fermentation of Tartary Buckwheat using L. plantarum TK9 and L. paracasei TK1501

Feng, L., Yu-feng, X., Peng, C., Liu, Y., & Wang, H. (2018) · Food Technology and Biotechnology · doi:10.17113/ftb.56.03.18.5540 · Cited by 30 · see citing works

Skeletal Fragility in Endogenous Hypercortisolism

Mazziotti, G., Delgado, A., Maffezzoni, F., Formenti, A., & Giustina, A. (2016) · Frontiers of hormone research · doi:10.1159/000443866 · Cited by 29 · see citing works

Levoketoconazole in the Treatment of Patients With Cushing’s Syndrome and Diabetes Mellitus: Results From the SONICS Phase 3 Study

Pivonello, R., Elenkova, A., Fleseriu, M., Feelders, R., Witek, P., Greenman, Y., Geer, E., Perotti, P., Saiegh, L., Cohen, F. J., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.595894 · Cited by 22 · see citing works

Clinical and biochemical manifestations of Cushing’s

Ntali, G., Grossman, A. B., & Karavitaki, N. (2015) · Pituitary · doi:10.1007/s11102-014-0631-4 · Cited by 27 · see citing works

Gender-Specific Differences in Clinical Profile and Biochemical Parameters in Patients with Cushing’s Disease: A Single Center Experience

Liu, X., Zhu, X., Zeng, M., Zhuang, Y., Zhou, Y., Zhang, Z., Yang, Y., Wang, Y., Ye, H., & Li, Y. (2015) · International Journal of Endocrinology · doi:10.1155/2015/949620 · Cited by 25 · see citing works

Lipid Abnormalities in Patients With Cushing’s Disease and Its Relationship With Impaired Glucose Metabolism

Sun, X., Feng, M., Lü, L., Zhao, Z., Bao, X., Deng, K., Yao, Y., Zhu, H., & Wang, R. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.600323 · Cited by 25 · see citing works

Long-term exposure to wind turbine noise at night and risk for diabetes: A nationwide cohort study

Poulsen, A. H., Raaschou‐Nielsen, O., Peña, A., Hahmann, A. N., Nordsborg, R. B., Ketzel, M., Brandt, J. G., & Sørensen, M. (2018) · Environmental Research · doi:10.1016/j.envres.2018.03.040 · Cited by 25 · see citing works

Bifidobacteria possess inhibitory activity against dipeptidyl peptidase-IV

Zeng, Z., Luo, J., Zuo, F., Yu, R., Zhang, Y., Ma, H., & Chen, S. W. (2015) · Letters in Applied Microbiology · doi:10.1111/lam.12510 · Cited by 24 · see citing works

Flattening of circadian glucocorticoid oscillations drives acute hyperinsulinemia and adipocyte hypertrophy

Tholen, S., Patel, R., Agas, A., Kovary, K. M., Rabiee, A., Nicholls, H. T., Bielczyk-Maczyńska, E., Yang, W., Kraemer, F. B., & Teruel, M. N. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111018 · Cited by 24 · see citing works

Synephrine and Its Derivative Compound A: Common and Specific Biological Effects

Dodonova, S. A., Михайловна, Ж. Е., Kryukov, A. A., Valiev, T. T., Игоревич, К. К., Kulikov, E. P., Budunova, I. V., Геннадиевна, Я. М., & Lesovaya, E. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417537 · Cited by 23 · see citing works

Clinical use of pasireotide for Cushing's disease in adults

Boscaro, M., Ceccato, F., & Scaroni, C. M. (2015) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s37314 · Cited by 24 · see citing works

Growth hormone deficiency in treated acromegaly and active Cushing's syndrome

Formenti, A. M., Maffezzoni, F., Doga, M., Mazziotti, G., & Giustina, A. (2017) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2017.03.002 · Cited by 24 · see citing works

Cushing Syndrome, Hypercortisolism, and Glucose Homeostasis: A Review

DeFronzo, R. A., & Auchus, R. J. (2025) · Diabetes · doi:10.2337/db25-0120 · Cited by 24 · see citing works

Outcome of glucose homeostasis in patients with glucocorticoid-induced osteoporosis undergoing treatment with bone active-drugs

Mazziotti, G., Maffezzoni, F., Doga, M., Hofbauer, L. C., Adler, R. A., & Giustina, A. (2014) · Bone · doi:10.1016/j.bone.2014.07.008 · Cited by 23 · see citing works

Prediction of vertebral fractures in cancer patients undergoing hormone deprivation therapies: Reliability of WHO fracture risk assessment tool (FRAX) and bone mineral density in real-life clinical practice

Mazziotti, G., Vena, W., Pedersini, R., Piccini, S., Morenghi, E., Cosentini, D., Zucali, P. A., Torrisi, R., Sporeni, S., Simoncini, E., et al. (2022) · Journal of bone oncology · doi:10.1016/j.jbo.2022.100421 · Cited by 22 · see citing works

Serum but not salivary cortisol levels are influenced by daily glycemic oscillations in type 2 diabetes

Bellastella, G., Maiorino, M. I., Bellis, A. D., Vietri, M. T., Mosca, C., Scappaticcio, L., Pasquali, D., Esposito, K., & Giugliano, D. (2015) · Endocrine · doi:10.1007/s12020-015-0777-5 · Cited by 22 · see citing works

Cushing’s syndrome in type 2 diabetes patients with poor glycemic control

Güngüneş, A., Şahi̇n, M., Demirci, T., Uçan, B., Çakır, E., Arslan, M. S., Ünsal, İ. Ö., Karbek, B., Çalışkan, M., Özbek, M., et al. (2014) · Endocrine · doi:10.1007/s12020-014-0260-8 · Cited by 21 · see citing works

Glucocorticoids and Diabetes.

Bauerle, K. T., & Harris, C. A. (2016) · Europe PMC (PubMed Central) · Cited by 20 · see citing works

Clinical pathological characteristics of breast cancer patients with secondary diabetes after systemic therapy: a retrospective multicenter study

Li, J., Wen, W., Liu, Z., Chen, C., Cheng, J., Yiping, G., Changhua, W., De-hua, Y., & Shengrong, S. (2015) · Tumor Biology · doi:10.1007/s13277-015-3380-8 · Cited by 19 · see citing works

Glucose metabolism disorders in patients with adrenal gland disorders: pathophysiology and management

Ioakim, K. J., Sydney, G. I., & Paschou, S. Α. (2019) · HORMONES · doi:10.1007/s42000-019-00147-z · Cited by 19 · see citing works

Long-Term Exposure to Road Traffic Noise and Incident Diabetes: A Cohort Study

Sørensen, M., Andersen, Z. J., Nordsborg, R. B., Becker, T., Tjønneland, A. M., Overvad, K., & Raaschou‐Nielsen, O. (2013) · ISEE Conference Abstracts · doi:10.1289/isee.2013.s-2-12-03 · Cited by 19 · see citing works

Holistic and Personalized Strategies for Managing in Elderly Type 2 Diabetes Patients

Yun, J., Kim, K., Ahn, Y., Han, K., & Ko, S. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2024.0310 · Cited by 18 · see citing works

Long-term green-Mediterranean diet may favor fasting morning cortisol stress hormone; the DIRECT-PLUS clinical trial

Alufer, L., Tsaban, G., Rinott, E., Kaplan, A., Meir, A. Y., Zelicha, H., Ceglarek, U., Isermann, B., Blüher, M., Stümvoll, M., et al. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1243910 · Cited by 18 · see citing works

Multiple once-daily subcutaneous doses of pasireotide were well tolerated in healthy male volunteers: a randomized, double-blind, placebo-controlled, cross-over, Phase I study

Beglinger, C., Hu, K., Wang, Y., Bouillaud, E., Darstein, C., Wang, Y.-F., & Mohideen, P. (2012) · Endocrine · doi:10.1007/s12020-012-9668-1 · Cited by 19 · see citing works

Lack of significant association between type 2 diabetes mellitus with longitudinal change in diurnal salivary cortisol: the multiethnic study of atherosclerosis

Spanakis, E. K., Wang, X., Sánchez, B. N., Roux, A. V. D., Needham, B. L., Wand, G. S., Seeman, T. E., & Golden, S. H. (2016) · Endocrine · doi:10.1007/s12020-016-0887-8 · Cited by 18 · see citing works

Role of SST, CORT and ghrelin and its receptors at the endocrine pancreas

Chanclón, B., Martínez‐Fuentes, A. J., & Gracia‐Navarro, F. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00114 · Cited by 17 · see citing works

Lipid Profiling Reveals Lipidomic Signatures of Weight Loss Interventions

Lin, K., Cheng, W., Shen, Q., Wang, H., Wang, R., Guo, S., Wu, X., Wu, W., Chen, P., Wang, Y., et al. (2023) · Nutrients · doi:10.3390/nu15071784 · Cited by 16 · see citing works

The Interplay Between Pituitary Health and Diabetes Mellitus – The Need for ‘Hypophyseo-vigilance’

Bhattacharya, S., Kalra, S., Dutta, D., Khandelwal, D., & Singla, R. (2020) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2020.16.1.25 · Cited by 15 · see citing works

Underlying mechanisms of glucocorticoid-induced β-cell death and dysfunction: a new role for glycogen synthase kinase 3

Delangre, E., Liu, J., Tolu, S., Maouche, K., Armanet, M., Cattan, P., Pommier, G., Bailbé, D., & Movassat, J. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04419-8 · Cited by 15 · see citing works

Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management

Scaroni, C., Zilio, M., Foti, M., & Boscaro, M. (2017) · Archive ouverte UNIGE (University of Geneva)

Diabetes Mellitus Secondary to Cushing’s Disease

Barbot, M., Ceccato, F., & Scaroni, C. M. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00284 · Cited by 78 · see citing works

Pathophysiology of Diabetes Mellitus in Cushing’s Syndrome

Pivonello, R., De Leo, M., Vitale, P., Cozzolino, A., Simeoli, C., De Martino, M. C., Lombardi, G., & Colao, A. (2010) · Neuroendocrinology · doi:10.1159/000314319 · Cited by 190 · see citing works

Das Verhalten der insulinähnlichen Aktivität im Blut bei Patienten mit einem Cushing-Syndrom während einer Glucose-Doppelbelastung

Schwarz, K., Weinges, K. F., Eymer, K. P., & Kopetz, K. (1962) · Verhandlungen der Deutschen Gesellschaft für Innere Medizin · doi:10.1007/978-3-642-96029-1_42 · Cited by 6 · see citing works

Diabetes in Cushing Disease

Mazziotti, G., Formenti, A., Frara, S., Maffezzoni, F., Doga, M., & Giustina, A. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0860-9 · Cited by 45 · see citing works